Chroma Therapeutics (WO 2005/019826 ) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Chroma Therapeutics (WO 2005/019826 ) General Information

Description

Developer of chemically modified chromosome fragments. The company's assets is involved in the development, made by scientists working at Chroma Therapeutics Limited and in the detection of chemically modified chromosome fragments, called nucleosomes, from cancer cells circulating in the blood of cancer patients.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Biotechnology
Acquirer
Primary Office
  • 93 Innovation Drive
  • Milton Park
  • Abingdon OX14 4RY
  • England, United Kingdom
+44 01235 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Chroma Therapeutics (WO 2005/019826 ) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Chroma Therapeutics (WO 2005/019826 )‘s full profile, request access.

Request a free trial

Chroma Therapeutics (WO 2005/019826 ) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Chroma Therapeutics (WO 2005/019826 )‘s full profile, request access.

Request a free trial